Tumor specificity of WNT ligands and receptors reveals universal squamous cell carcinoma oncogenes
Open Access
- 19 July 2022
- journal article
- research article
- Published by Springer Nature in BMC Cancer
- Vol. 22 (1) , 1-14
Abstract
Background: The WNT signal pathway has myriad family members, which are broadly involved in embryonic development and human cancer. Over-activation of WNT-β-Catenin signaling promotes cancer cell proliferation and survival. However, how diverse components of WNT signaling specifically engaged in distinct tumor types remains incompletely understood. Methods: We analyzed the transcriptomic profiling of WNT ligands and receptors/co-receptors among 26 different tumor types to identify their expression pattern, and further verified these results using clinical oral squamous cell carcinoma (OSCC) and lung squamous cell carcinoma (LUSC) samples. At the same time, we also detected WNT7B expression in oral inflammation and carcinoma, and constructed stable WNT7B knockdown OSCC cell lines to study the effects of WNT7B on the cell migration and invasion ability. Results: We found a group of tumor-specific WNT members, including a panel of squamous cell carcinomas (SCCs) specific upregulated WNT ligands and receptors, WNT5A, WNT7B, FZD7 and GPC1. We further revealed a significant correlation between these protein expression characteristics and clinical outcomes of OSCC and LUSC patients. Moreover, WNT7B was demonstrated to contribute to the development of oral chronic inflammation and OSCC, partly due to promoting the invasion ability of tumor cells. Conclusions: These results demonstrate that the function of WNT ligands and receptors in specific tumors depends on the origination of tumor tissue type. Collectively, they support the use of WNT components as a highly specific target for pan-tissue-type originated tumors.Keywords
Funding Information
- Department of Science and Technology of Sichuan Province of China (2022YFS0597, 2021ZYD0093)
- National Natural Science Foundation of China (81673338)
This publication has 40 references indexed in Scilit:
- The complex world of WNT receptor signallingNature Reviews Molecular Cell Biology, 2012
- Canonical Wnt signaling regulates Slug activity and links epithelial–mesenchymal transition with epigenetic Breast Cancer 1, Early Onset (BRCA1) repressionProceedings of the National Academy of Sciences, 2012
- Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumorsProceedings of the National Academy of Sciences, 2012
- Aberrant activation of Wnt/β-catenin signaling pathway contributes to the sequential progression of DMBA-induced HBP carcinomasOral Oncology, 2012
- Msx2 is required for TNF-α-induced canonical Wnt signaling in 3T3-L1 preadipocytesBiochemical and Biophysical Research Communications, 2011
- Matrix Metalloproteinases: Regulators of the Tumor MicroenvironmentCell, 2010
- The Wnt/β-Catenin Pathway Is Required for the Development of Leukemia Stem Cells in AMLScience, 2010
- Structure–activity relationship studies of small-molecule inhibitors of Wnt responseBioorganic & Medicinal Chemistry Letters, 2009
- The Genomic Landscapes of Human Breast and Colorectal CancersScience, 2007
- Genomic Analysis Defines a Cancer-Specific Gene Expression Signature for Human Squamous Cell Carcinoma and Distinguishes Malignant Hyperproliferation from Benign HyperplasiaJournal of Investigative Dermatology, 2006